Goldman Sachs’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24M Buy
1,005,743
+483,107
+92% +$13.4M ﹤0.01% 2265
2025
Q4
$14.5M Sell
522,636
-796,017
-60% -$20.3M ﹤0.01% 2693
2025
Q3
$32M Buy
1,318,653
+35,530
+3% +$707K ﹤0.01% 1808
2025
Q2
$21.8M Buy
1,283,123
+605,961
+89% +$10.6M ﹤0.01% 2049
2025
Q1
$13.2M Sell
677,162
-42,702
-6% -$1.12M ﹤0.01% 2429
2024
Q4
$17.9M Buy
719,864
+39,016
+6% +$996K ﹤0.01% 2233
2024
Q3
$16.7M Sell
680,848
-103,715
-13% -$2.68M ﹤0.01% 2229
2024
Q2
$18.4M Buy
784,563
+232,351
+42% +$5.71M ﹤0.01% 1954
2024
Q1
$18.2M Buy
552,212
+68,062
+14% +$2.12M ﹤0.01% 1923
2023
Q4
$13.2M Buy
484,150
+22,433
+5% +$557K ﹤0.01% 2273
2023
Q3
$11.1M Sell
461,717
-264,308
-36% -$7.09M ﹤0.01% 2303
2023
Q2
$23.2M Buy
726,025
+67,767
+10% +$2.2M 0.01% 1720
2023
Q1
$20.2M Sell
658,258
-360,134
-35% -$14.2M 0.01% 1815
2022
Q4
$39.8M Sell
1,018,392
-33,284
-3% -$1.49M 0.01% 1356
2022
Q3
$50.1M Buy
1,051,676
+97,749
+10% +$5.58M 0.01% 1116
2022
Q2
$36.9M Buy
953,927
+124,680
+15% +$4.96M 0.01% 1358
2022
Q1
$47.5M Sell
829,247
-144,771
-15% -$9.5M 0.01% 1318
2021
Q4
$77.6M Sell
974,018
-70,064
-7% -$6M 0.02% 976
2021
Q3
$90.8M Buy
1,044,082
+396,038
+61% +$39.8M 0.02% 816
2021
Q2
$83.4M Sell
648,044
-86,173
-12% -$6.87M 0.02% 854
2021
Q1
$58.8M Sell
734,217
-106,976
-13% -$10.2M 0.02% 1041
2020
Q4
$68.7M Buy
841,193
+529,904
+170% +$26.1M 0.02% 873
2020
Q3
$7.66M Sell
311,289
-3,248
-1% -$80.6K ﹤0.01% 2554
2020
Q2
$8.81M Sell
314,537
-48,421
-13% -$1.04M ﹤0.01% 2372
2020
Q1
$6.53M Buy
+362,958
New +$7.89M ﹤0.01% 2426

Other funds holding BEAM